SAREPTA THERAPEUTICS, INC. Accumulated Other Comprehensive Income
SAREPTA THERAPEUTICS, INC. (SRPT) had Accumulated Other Comprehensive Income of -$565.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-05
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$565.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$121.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $272.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $220.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$565.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | -$121.00K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $272.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $220.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$51.00K 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $34.00K 10-Q · filed 2025-05-06 | |
| 2024-12-31 | -$218.00K 10-K · filed 2026-03-02 | |
| 2024-09-30 | $2.25M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | -$1.03M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | -$691.00K 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $918.00K 10-K · filed 2025-02-28 | |
| 2023-09-30 | -$638.00K 10-Q · filed 2023-11-01 | |
| 2023-06-30 | -$1.05M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | -$419.00K 10-Q · filed 2023-05-02 | |
| 2022-12-31 | -$1.66M 10-K · filed 2024-02-28 | |
| 2022-09-30 | -$3.21M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | -$2.48M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | -$306.00K 10-Q · filed 2022-05-04 | |
| 2021-12-31 | -$20.00K 10-K · filed 2023-02-28 | $20.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | -$20.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $2.00K 10-Q · filed 2021-08-04 | |
| 2021-03-31 | -$3.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $3.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | -$6.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $6.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $624.00K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $50.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $75.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $82.00K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $19.00K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | -$99.00K 10-K · filed 2020-02-26 | |
| 2018-09-30 | $8.00K 10-Q · filed 2018-10-31 | |
| 2018-06-30 | -$361.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$643.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | -$379.00K 10-K · filed 2019-02-28 | |
| 2017-09-30 | -$12.00K 10-Q · filed 2017-11-01 | |
| 2017-06-30 | -$38.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | -$55.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | -$120.00K 10-K · filed 2018-03-01 | |
| 2016-06-30 | $1.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$5.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | -$111.00K 10-K · filed 2017-02-28 | |
| 2015-09-30 | -$1.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$19.00K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$17.00K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$95.00K 10-K · filed 2016-02-25 | |
| 2014-09-30 | -$55.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | -$35.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $59.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $0.00 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |